about
Under-recognised co-morbidities in idiopathic pulmonary fibrosis: A reviewHemodynamic effects of ambrisentan-tadalafil combination therapy on progressive portopulmonary hypertension.Emerging Metabolic Therapies in Pulmonary Arterial Hypertension.Saudi guidelines on the treatment and management of pulmonary hypertension 2014: Updates a fresh understanding of pulmonary vascular diseases in the developing world.Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updatesTwo-dimensional echocardiography in the assessment of long-term prognosis in patients with pulmonary arterial hypertensionSignificance of main pulmonary artery dilation on imaging studies.Upregulated expression of STIM2, TRPC6, and Orai2 contributes to the transition of pulmonary arterial smooth muscle cells from a contractile to proliferative phenotype.Prevalence and hospital discharge status of human immunodeficiency virus-associated pulmonary arterial hypertension in the United States.Pulmonary Hypertension: Scientometric Analysis and Density-Equalizing Mapping.Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).Post splenectomy related pulmonary hypertension.2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.Plasma 12- and 15-hydroxyeicosanoids are predictors of survival in pulmonary arterial hypertension.Novel approaches to pulmonary arterial hypertension drug discoveryBaseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients.Platelets from pulmonary hypertension patients show increased mitochondrial reserve capacity.Riociguat for pulmonary hypertension.The Post-Anesthetic Care of Pediatric Patients With Pulmonary Hypertension.The pathophysiology of pulmonary hypertension in left heart disease.The Role of Echocardiography in the Evaluation of Pulmonary Arterial Hypertension.Aneurysm of the Pulmonary Artery, a Systematic Review and Critical Analysis of Current Literature.Reduced carboxylesterase 1 is associated with endothelial injury in methamphetamine-induced pulmonary arterial hypertension.The Evolving Landscape of Exercise-Induced Pulmonary Hypertension.Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension.Ambrisentan: a review of its use in pulmonary arterial hypertension.Atrial septal defect in adults: does repair always mean cure?Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.Features and Outcomes of Methamphetamine Associated Pulmonary Arterial Hypertension.Prognostic relevance of elevated pulmonary arterial pressure assessed non-invasively: Analysis in a large patient cohort with invasive measurements in near temporal proximity.Right ventricular longitudinal strain is diminished in systemic sclerosis compared with idiopathic pulmonary arterial hypertension.Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg.DRUG INDUCED PULMONARY ARTERIAL HYPERTENSION: A PRIMER FOR CLINICIANS AND SCIENTISTS.Cardiovascular parameters of chest CT scan in estimating pulmonary arterial pressure in patients with pulmonary hypertension.
P2860
Q26781255-437AAE33-2135-4AB1-9811-BEE5BCC498DCQ33418891-1E51E25A-3C47-465A-B8E4-6819E624A97AQ33608219-E50330A3-704B-4E02-B1E8-00379F2D6E34Q33815340-B1190146-081A-4A06-9B8A-80C7DF1AB194Q33965904-AD8B39AD-6877-4070-9EB3-F722D19D6F89Q34653817-D3BB329F-CFC4-4B7F-9BC5-28F7F002C06CQ34984664-B718BC3B-A876-45B2-961C-B4FAF9A0E6A9Q35437211-AC79280D-6082-4C25-9285-36F536D939D4Q36016513-F632A968-49AD-4C48-B026-E638A5209774Q36239561-C0BBA386-2644-426B-8D9B-AC11D2EBC937Q36398814-4E10960C-4367-48A0-83F6-4BEB0A76A521Q36653460-83C75738-4E12-4603-8130-2F31E031D5BAQ36777766-DC8E6D2B-CFF2-49AC-A1DD-901EC3B45BC6Q36908857-17ADF887-FE6F-4470-B1E5-9AC4B12D8769Q37066778-D2DD8A2A-9F10-4DBE-AA0C-AAD303085D8AQ37206944-DAF5722D-B1B2-41BF-A579-D706750B7417Q37677425-E212FB20-A87B-4FA4-A086-F2CA44320166Q38192059-F97D4409-9B28-4B68-BFF8-C16936FF7BDDQ38541758-B3F9CFFC-9183-4C01-A738-948F179E64E3Q38616615-CA41844F-79ED-4025-89E6-A5F2CA385140Q38621926-7EC98EDB-9ACC-4B8D-AC0F-5BADE159D349Q38629665-CD4F87E8-6FFC-4A94-A787-0795C07BBD85Q38803346-3D6A32EB-7F81-4BAF-97E3-B8CA5BCD6224Q38833386-D6DD80A2-8AB8-42EC-AE45-341D30247544Q38859147-79D09C00-0B9E-4790-9987-E757DCE85B64Q39251587-B9AAB18D-7AB3-4418-B976-1D68921BE62FQ43101531-DD588328-BC80-47D8-9D99-E4BA5604CF9BQ45073137-C5D441AF-8842-407B-B3F1-7435782C895CQ46115864-4AB7555B-080D-4132-9199-56BDBF3B96DFQ47851665-FF4A3DB8-FA28-4123-B811-AF7AC558AAD6Q49788194-BF72EA0E-F3F2-400B-9F9A-5847A4C3806BQ50098235-445203AF-F5BC-466A-BBB3-8A4DCFB09F0DQ50124360-E5B4624F-9C22-4CEA-9A31-705B6D306B7DQ51437646-FC58F969-DCC1-4E6B-B12E-68916DB17BA5
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The Fifth World Symposium on Pulmonary Hypertension.
@en
The Fifth World Symposium on Pulmonary Hypertension.
@nl
type
label
The Fifth World Symposium on Pulmonary Hypertension.
@en
The Fifth World Symposium on Pulmonary Hypertension.
@nl
prefLabel
The Fifth World Symposium on Pulmonary Hypertension.
@en
The Fifth World Symposium on Pulmonary Hypertension.
@nl
P1476
The Fifth World Symposium on Pulmonary Hypertension
@en
P2093
Gerald Simonneau
P356
10.1016/J.JACC.2013.10.030
P407
P433
P577
2013-12-01T00:00:00Z